Testing effectiveness (Phase 2)Study completedNCT00004211What this trial is testingVaccine Therapy in Treating Patients With Metastatic Prostate CancerWho this might be right forProstate Cancer Duke University 17
Not applicableStudy completedNCT00716911What this trial is testingMeasuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more City of Hope Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00964171What this trial is testingEfavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Institut Bergonié 19
Testing effectiveness (Phase 2)Study completedNCT01164007What this trial is testingBevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic MelanomaWho this might be right forMalignant Melanoma Hoffmann-La Roche 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07832292What this trial is testingJNJ-101556143 in Participants With Metastatic Prostate CancerWho this might be right forProstatic Neoplasms Janssen Research & Development, LLC 100
Not applicableStudy completedNCT06980792What this trial is testingSurgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver MetastasesWho this might be right forPancreas NeoplasmsLiver MetastasisPancreas Ductal Adenocarcinoma+3 more Azienda Ospedaliero-Universitaria di Modena 90
Not applicableStudy completedNCT02322736What this trial is testingProspective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Use and ORRWho this might be right forMetastatic Colorectal Cancer Amgen 218
Early research (Phase 1)Ended earlyNCT05904236What this trial is testingSafety and Tolerability of Intravenous Administration of ICVB-1042Who this might be right forPatients With Advanced Solid Tumors IconOVir Bio 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686367What this trial is testingTesting the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare CancersWho this might be right forMetastatic Myxoid LiposarcomaMetastatic Synovial SarcomaUnresectable Myxoid Liposarcoma+1 more National Cancer Institute (NCI) 42
Not applicableLooking for participantsNCT06221800What this trial is testingAssess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse EffectsWho this might be right forNon Small Cell Lung Cancer University of California, Irvine 82
Early research (Phase 1)Ended earlyNCT00996892What this trial is testingSafety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forSolid Tumors Genentech, Inc. 178
Early research (Phase 1)Ended earlyNCT00100971What this trial is testingVaccine Therapy in Treating Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Boston Medical Center 9
Not applicableUnknownNCT06155136What this trial is testingRWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal IrinotecanWho this might be right forPancreatic Cancer Metastatic Servier Affaires Médicales 163
Testing effectiveness (Phase 2)Study completedNCT03562871What this trial is testingIO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLCWho this might be right forNSCLC IO Biotech 109
Testing effectiveness (Phase 2)Ended earlyNCT00531115What this trial is testingPhase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.Who this might be right forMetastatic Colorectal Cancer Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 28
Not applicableUnknownNCT04917276What this trial is testingTreatment Response Prediction System of mCRC Patients Based on CTCWho this might be right forColorectal Cancer Stage IVCirculating Tumor Cell Fudan University 100
Early research (Phase 1)Active Not RecruitingNCT02474368What this trial is testingStudy Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and NeckWho this might be right forRecurrent Head and Neck CarcinomaHead and Neck Cancer MetastaticHead or Neck Cancer Dana-Farber Cancer Institute 21
Post-approval studies (Phase 4)Looking for participantsNCT05376878What this trial is testingAn Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain MetastasisWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain City of Hope Medical Center 10
Testing effectiveness (Phase 2)Ended earlyNCT00321308What this trial is testingTrial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small Cell Lung Pfizer 36
Testing effectiveness (Phase 2)Study completedNCT00735917What this trial is testingSaracatinib in Treating Patients With Previously Treated Metastatic Pancreatic CancerWho this might be right forAdenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic Cancer National Cancer Institute (NCI) 19